Healio

Patients with unexplained chorea should be tested for antiphospholipid antibodies

Please provide your email address to receive an email when new articles are posted on . Most patients with chorea and antiphospholipid antibody were women, with chorea onset at an average age of 22.8 ...
MedPage Today

HIV Patient With Movement Disorder Has Different Symptoms on Left and Right Sides

A 59-year-old woman with a background of HIV living with an uncontrollable movement disorder presented to Eoghan Donlon, MB, BCh BAO, MRCPI, of the Mater Misericordiae University Hospital in Dublin, ...
Labroots

Breakthrough Study Reveals Promising Treatment for Chorea in Huntington's Disease

Huntington's disease is a genetic neurodegenerative disorder that affects both motor and cognitive function and gradually reduces the independence and quality of life of those affected. One of the ...
Worksop Guardian

Nottinghamshire Healthcar provides virtual reality to reduce involuntary movements in Huntingdon’s patient

A patient with Advanced Huntington’s Disease has seen amazing results to help improve her involuntary movements (also known as ‘Chorea’) following Nottinghamshire Healthcare’s Specialist Palliative ...
Morningstar

Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA® (valbenazine) Capsules for Huntington ...

SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the open-label KINECT®-HD2 study demonstrating an established long-term safety profile ...